# Harith Rajagopalan

Principais episódios de podcast
Atualizada:

Can Fractyl Labs and Cala Health go where only drugs have gone before?

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMas…

2003 Cancer - Interview with Harith Rajagopalan

Interview with Harith Rajagopalan An interview with Harith Rajagopalan, a scientist in Dr. Vogelstein's lab.

Delivering New Treatments for Type 2 Diabetes with Dr. Harith Rajagopalan

This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE --- As we celebrate the 100th anniversary of the discovery of insulin, it may seem that type 2 diabetes treatment has come a long way. However, the…

In the News.. Tandem's Mobi approved, T1D and aging study, kayaker with diabetes sets record, and more!

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new insulin pump gets FDA approval, once-weekly basal insulin for type 2 gets through another trial, New Jersey caps insulin prices for some, possible link between ability t…

Beyond Ozempic: New Therapies for Post-Obesity Drug Weight Management, with Dr. Harith Rajagopalan

Send us Fan Mail In this episode of Causes or Cures, Dr. Eeks chats with cardiologist, physician-scientist and CEO of Fractyl Health Dr. Harith Rajagopalan about solutions his company is developing for the problem of keeping weight off after someone stops taking the obesity/weight loss medication, …

Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan

Send a text CEO and Co-Founder of Fractyl Health ($GUTS) Dr. Harith Rajagopalan joins On The Pen to discuss their #Revita and #Rejuva programs for type 2 diabetes and obestityhttps://www.fractyl.com/ Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%! 🤝 Visit Our Sponsors!OTPLinks.co…

Ep 23 - Can Fractyl Labs and Cala Health go where only drugs have gone before?

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMas…

Retatrutide News That Could Change Everything for GLP-1 Compounds

Send a text SUPPORT OUR WORK:OTPLinks.com 💉 Story 1 — Fractyl Health’s One-and-Done Gene Therapy for ObesityFractyl Health just dropped preclinical results showing their GLP-1 + GIP gene therapy candidate RJVA-002 produced almost 30% weight loss in mice after a single dose. I sat down with Dr. Hari…

Harith Rajagopalan: Restoring Patient Health from Metabolic Disease

Harith Rajagopalan, M.D., Ph.D., Co-Founder & CEO, Fractyl Dr. Harith Rajagopalan is co-founder and CEO of Fractyl, having started the company while serving as an Entrepreneur-in-Residence at General Catalyst Partners. Prior to founding Fractyl, Harith was an academic cardiologist and physician-sc…

Episode 43: The one where I discuss all things Fractyl with Dr. Harith Rajagopalan

Resetting the Metabolic Setpoint: Duodenal Mucosal Resurfacing (DMR) and the Future of Obesity Care with Dr. Harith Rajagopalan Is the duodenum the "early warning beacon" for metabolic disease? In this episode, we sit down with Dr. Harith Rajagopalan, MD, PhD, Co-Founder and CEO of Fractyl Health,…